New pacemaker for the diaphragm aims to free patients from ventilators faster
NCT ID NCT07477054
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a device called AeroPace that electrically stimulates the nerve controlling the diaphragm, the main breathing muscle. It is for adults who have been on a mechanical ventilator for at least 4 days and are having trouble weaning off. The goal is to see if the device is safe and helps patients breathe on their own within 30 days.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
AeroPace System (device that electrically stimulates the phrenic nerve to contract the diaphragm)
What this could lead to
If successful, this device could help people on breathing machines wean off ventilation faster and reduce complications from diaphragm weakness.
What could go wrong
This is a post-approval study collecting real-world data, not a randomized trial, so results may not prove the device is better than standard care. Risks include device-related serious adverse events.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VENTILATOR INDUCED DIAPHRAGM DYSFUNCTION are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••